Bioequivalence and Bioavailability Forum 16:25 CEST

Main page Policy/Terms of Use Abbreviations Latest Posts

 Log in |  Register |  Search

ElMaestro
Hero

Denmark,
2017-09-29 12:41

Posting: # 17841
Views: 1,845
 

 I sometimes regret I did not go to plumbing school in stead [Off Topic]


if (3) 4

Best regards,
ElMaestro

"(...) targeted cancer therapies will benefit fewer than 2 percent of the cancer patients they’re aimed at. That reality is often lost on consumers, who are being fed a steady diet of winning anecdotes about miracle cures." New York Times (ed.), June 9, 2018.
ElMaestro
Hero

Denmark,
2017-10-04 09:48

@ ElMaestro
Posting: # 17846
Views: 1,350
 

 Tax payer money at work


if (3) 4

Best regards,
ElMaestro

"(...) targeted cancer therapies will benefit fewer than 2 percent of the cancer patients they’re aimed at. That reality is often lost on consumers, who are being fed a steady diet of winning anecdotes about miracle cures." New York Times (ed.), June 9, 2018.
nobody
Senior

2017-10-04 11:48

@ ElMaestro
Posting: # 17848
Views: 1,317
 

 Tax payer money at work

...saw a figure yesterday that this patent evergreening trick will cost the US tax payer some 10.6 BILLION $$$. So: every right to investigate, or?

Kindest regards, nobody
ElMaestro
Hero

Denmark,
2017-10-04 12:19

@ nobody
Posting: # 17853
Views: 1,319
 

 Tax payer money at work

Hi nobody,

» So: every right to investigate, or?

I agree 120%.

Regrettably keelhauling has gone a little bit out of fashion nowadays. It is associated with less bureaucratic burden and produces impressive results in a short time frame.

if (3) 4

Best regards,
ElMaestro

"(...) targeted cancer therapies will benefit fewer than 2 percent of the cancer patients they’re aimed at. That reality is often lost on consumers, who are being fed a steady diet of winning anecdotes about miracle cures." New York Times (ed.), June 9, 2018.
Back to the forum Activity
 Thread view
Bioequivalence and Bioavailability Forum |  Admin contact
18,606 posts in 3,959 threads, 1,208 registered users;
online 20 (2 registered, 18 guests [including 19 identified bots]).

EMEA. The European Medicines Evaluation Agency.
The drug regulatory agency of the European Union.
A statistician-free zone.    Stephen Senn

The BIOEQUIVALENCE / BIOAVAILABILITY FORUM is hosted by
BEBAC Ing. Helmut Schütz
HTML5 RSS Feed